3 ·Filed Jul 27, 2026

INSP

Inspire Medical Systems, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed2mo ago SEC0001104659-26-087215
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

This is a routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Carrel, which would provide actionable information on insider conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
INSP ▲ +17.51% at T+20d
NEUTRAL call ✓ call won +17.51% · α vs SPY +14.13% · entry $51.97 → $61.07
Next anchor: T+60d in 18d
Latest observation: T+47 +55.00% FF3 residual α
Entry anchored
Jul 27, 03:59 PM ET
via exchange tick
T+1d
-1.73%
call -1.73% · α -0.19%
$51.07
settled 2mo ago
T+5d
+0.48%
call +0.48% · α -1.79%
$52.22
settled 2mo ago
T+20d
+17.51%
call +17.51% · α +14.13%
$61.07
settled 6w ago
T+60d
—
call — · α —
—
in 18d

Price Chart

Loading chart...

Executive Summary

Michael H. Carrel filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, reporting no securities owned. The filing is a routine administrative requirement for a new insider and includes a standard power of attorney authorizing company officers to execute future filings. It carries no material financial or strategic implications for Inspire Medical Systems.

Key Facts

  • Michael H. Carrel filed a Form 3 initial statement of beneficial ownership on 2026-07-27, reporting zero securities owned.
  • The filing includes a power of attorney (Exhibit 24) authorizing Bryan Phillips and Jim DeBuse to execute future Section 16 filings on Carrel's behalf.
  • Carrel's business address is c/o Inspire Medical Systems, Inc., 5500 Wayzata Blvd., Suite 1600, Golden Valley, MN 55416.

Financial Impact

No financial impact — zero securities reported and no transactions disclosed.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
36% bullish (25 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001104659-26-087215
Document: 0001104659-26-087215-index-headers.html0001104659-26-087215
Document: 0001104659-26-087215-index.html0001104659-26-087215
Document: 0001104659-26-087215.txt0001104659-26-087215
8 reports for INSP
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for INSP — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
3
NEUTRAL ★ 1/10
$51.97 $61.07▲ +17.51%▲ +14.13%$69.97 (+34.64%)
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$50.93 $61.47▲ +20.70%▲ +17.40%$69.97 (+37.38%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$50.40 $61.69▲ +22.40%▲ +19.50%$69.97 (+38.83%)
Jul 6, 2026
12w ago
Press Release
BEARISH ★ 6/10
$49.45 $50.21▼ −1.54%▼ −2.10%$69.97 (−41.50%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 5/10
$42.70 $51.76▲ +21.22%▲ +19.44%$69.97 (+63.86%)
May 8, 2026
21w ago
144
NEUTRAL ★ 2/10
$43.35 $42.21▼ −2.63%▼ −2.33%$69.97 (+61.41%)
Apr 6, 2026
25w ago
Press Release
NEUTRAL ★ 3/10
$54.14 $54.84▲ +1.29%▼ −7.69%$69.97 (+29.24%)
Mar 20, 2026
28w ago
DEFA14A
NEUTRAL ★ 2/10
$53.72 $56.97▲ +6.05%▼ −3.27%$69.97 (+30.25%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (38h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access